Register for the GLA:D Canada Learning Network sessions for people who would like more information about hip and knee osteoarthritis. Registration is open for 8 consecutive sessions in June, July, August and September, that are 45-min long and are hosted virtually using Zoom.
May 20th is the International Clinical Trials Day! CAPA Vice-President, Laurie Proulx, spoke at this year’s Clinical Trials Ontario conference about patient preferences in rheumatology clinical trials.
The Arthritis Society is inviting individuals who are living with arthritis to participate as volunteer members of their Online Consumer Panels. You will have the opportunity to share your knowledge, experience and feedback to help develop educational resources and activities to improve the quality of life of people impacted by arthritis.
Patients with Autoimmune Conditions and/or on Immune Suppressing Medications Invited to Participate in Short Survey
You are invited to participate in the research study, entitled COVID-19 vaccination in patients with autoimmune disease: A Discrete Choice Experiment. Please answer the survey questions to help us better understand your preferences around having the COVID-19 vaccine.
Canadian Pain Task Force released its final report An Action Plan for Pain in Canada. Add your voice to the call to #PrioritizePain. Read the report and learn how you can make your voices heard on the issue of pain in Canada.
Dr. Stephanie Garner will be holding a Zoom session for all rheumatology patients to answer your COVID Vaccine related questions.
On April 25th, CAPA hosted the webinar with rheumatologists Drs. Claire Barber and Glen Hazelwood and health researcher and occupational therapist, Dr. Karine Toupin April who are leading projects that support #shareddecisionmaking in rheumatology. Watch this video to learn more!
Are you considering talking to your healthcare provider about biosimilars or has your healthcare provider talked to you already about biosimilars? We have put together some questions that might be helpful to be part of a conversation with your healthcare provider about biosimilars and brand name biologics.
Over the summer, CAPA had participated in the development of a CRA virtual care statement, voiced the patient perspective on proposed drug pricing changes on patients and did an extensive survey on sexual and reproductive health in collaboration with other patient groups. We had planned lots of fun activities for September, the Arthritis Awareness month!
This month, CAPA team has been involved in the development of the video on a biosimilar medication. launching the new parenting resources, speaking at the webinar on an action plan for pain in Canada and many more!
This month CAPA team has been busy advocating for the second dose of the COVID-19 vaccine for people with autoimmune rheumatic conditions, updating and launching our pregnancy resources and being at the forefront of "A call for action to #PrioritizePain" campaign. Learn more by reading our newsletter!
In this newsletter edition, we invite you to provide input to the three very important surveys on the sexual and reproductive health in arthritis care, the COVID-19 vaccine access and the COVID-19 Global Rheumatology Alliance. Register and join us for the Shared decision making webinar on April 25th to be hosted by Dr. Claire Barber, Dr. Glen Hazlewood and Dr. Karine Toupin April.
This month we continue informing you about the rollout of the COVID-19 vaccine which is currently underway and what this means to many people living with rheumatic diseases. Read more.
This month CAPA Board members were involved in the guideline panel discussions on the new COVID-19 vaccination recommendation from the Canadian Rheumatology Association, attended and participated in the annual 2021 Canadian Arthritis Research Conference, contributed as panel moderators and presenters, and many more.
Welcome to 2021! "The 2020 was a year like no other where our homes have become the focus of our lives, our workplace, a classroom, and our sanctuarys", said the CAPA President Linda Wilhelm. January 2021 had been a very busy start of the new year for CAPA team, as we have been engaged in the development of the COVID-19 vaccine decision aid, writing a letter to NACI and public health officials across Canada, providing patient input to CADTH submissions for new drugs and many more.
2020 has been a challenging year for so many of us! As CAPA team, we have tried our best to support the arthritis community throughout the pandemic by addressing drug shortages, developing evidence-based resources, hosting a virtual fashion show and many more. To end the year on a lighter note, the CAPA Board of Directors wish you the best holiday season and best of luck in the year ahead!
When you live with arthritis,
information is your most important tool.
The Canadian Arthritis Patient Alliance (CAPA) works with various groups in the arthiritis community to ensure the voice of people living with arthritis is heard and to bring you up-to-date information on issues that affect the arthritis community. We work with healthcare professionals, health organizations, clinicians, industry, health charities, researchers, and various levels of government.
We keep Canadian people living with arthritis and their support groups understand more about their disease and have a voice in managing it.